The complementary and alternative therapy (CAT) market in the United Arab Emirates (UAE) has witnessed significant growth in recent years, reflecting a global trend of holistic health practices. The market is segmented based on therapy types, including acupuncture, chiropractic, homeopathy, naturopathy, psychology, counseling, and life coaching. As of 2023, significant regulatory progress has been made to standardize practices across different Emirates.
Read More »September 24, 2024
The Middle East complementary and alternative medicine market size was estimated at USD 12.26 billion in 2023 and is projected to grow at a CAGR of 22.77% from 2024 to 2030. This can be attributed to increasing demand for complementary and alternative medicines due to the rising consumer base, increasing awareness about the benefits of complementary and alternative medicines, and a comparatively less expensive alternative to traditional medicine.
Read More »July 8, 2024
The global complementary and alternative medicine for anti-aging & longevity market size was estimated at USD 63.60 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.5% from 2024 to 2030. The growth of the market is driven by increasing awareness of holistic wellbeing and a growing aging population.
Read More »January 2, 2024
The Europe complementary and alternative medicine market size was valued at USD 27.44 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 20.89% from 2021 to 2028. Complementary and alternative medicine (CAM) is considered a traditional treatment and the market is majorly driven by the growing awareness regarding the numerous associated benefits.
Read More »December 23, 2021
The global complementary and alternative medicine market size was valued at USD 144.68 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 25.3% from 2024 to 2030. The growing awareness regarding Complementary and Alternative Medicine (CAM), increasing disposable income, and government initiatives to boost CAM are some of the major factors driving the market growth.
Read More »January 18, 2024
The UAE complementary and alternative medicine market size was estimated at USD 2.99 billion in 2023 and is projected to grow at a CAGR of 11.94% from 2024 to 2030. The market growth can be attributed to the increasing demand for complementary and alternative medicine (CAM) therapy due to the rising incidence of chronic diseases across the UAE region. In addition, rising awareness about chronic disease among physicians & patients and increasing healthcare expenditure in various regions propel the overall market growth.
Read More »June 11, 2024
The U.S. complementary and alternative medicine market size was estimated at USD 28.1 billion in 2023 and is projected to grow at CAGR of 23.9% from 2024 to 2030. The increasing prevalence of chronic diseases, the growing demand for holistic health approaches, the increasing awareness, acceptance & improved accessibility, and affordability of CAM therapies are driving the growth in the U.S. According to the National Center for Complementary and Integrative Health survey published in 2022, over the past 20 years, the U.S. adults increased their overall use of complementary health approaches, specifically for managing pain.
Read More »June 26, 2024
The health insurance for UAE complementary and alternative therapy market size was valued at USD 155.08 million in 2023 and is projected to grow at a CAGR of 17.17% from 2024 to 2030. There is a growing number of government initiatives and regulations that improve health coverage for these treatments, along with the increasing availability of coverage plans from providers, reflects a rising consumer preference for holistic health solutions.
Read More »September 23, 2024
The global personalized medicine market was valued at USD 529.28 billion in 2023 and is projected to grow at a CAGR of 8.20% from 2024 to 2030. The personalized medicine market is driven majorly by the growing demand for novel drug discovery to combat the rising incidence of cancers and other diseases across the globe.
Read More »June 20, 2024
The research, development, and launch of gene therapy products are driven by several key factors, including enhanced regulatory support, rising patient demand, advancements in gene editing technologies, and the growing market potential for innovative treatments targeting chronic diseases. These therapies hold immense promise for treating previously untreatable genetic disorders, as evidenced by the approval of high-profile therapies like Luxturna and Zolgensma, which have shown impressive effectiveness in treating rare inherited conditions.
Read More »October 1, 2024